{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:35:49Z","timestamp":1752230149242},"reference-count":18,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec id=\"st1\">\n<jats:title>Background : <\/jats:title>\n<jats:p>Neurological manifestations in immunoglobulin G4-related diseases (IgG4-RD) are rare and documented in &lt;2% of cases. It commonly involves pachymeninges forming hypertrophic pachymeningitis and rarely forms tumor-like masses.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st2\">\n<jats:title>Case Description: <\/jats:title>\n<jats:p>We present our experience with a biopsy-proven case of IgG4-RD presenting with an intracranial extradural tumor-like mass infiltrating the temporal lobe. The patient was treated with high doses of corticosteroids followed by slow tapering. The neurological manifestations gradually improved and resolved after 2 months with a cerebral MRI showing a significant reduction in the tumoral size.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st3\">\n<jats:title>Conclusion: <\/jats:title>\n<jats:p>When it comes to intracranial mass, IgG4-RD neuropathy is one of the rarest differential diagnoses for the central nervous system tumors. Early recognition of IgG4-RD and appropriate establishment of its long-term treatment may avoid unnecessary investigations and morbidity.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/sni_149_2022","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T11:35:56Z","timestamp":1653651356000},"page":"224","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunoglobulin G4-related disease presenting as an intracranial mass extended from the infratemporal fossa"],"prefix":"10.25259","volume":"13","author":[{"given":"Kais","family":"Maamri","sequence":"first","affiliation":[{"name":"Department of Neurosurgery Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Amine Hadj","family":"Taieb","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassen","family":"Elkahla","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rym","family":"Hadhri","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Dermoul","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"10.25259\/SNI_149_2022\/ref-1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11940-017-0450-9","article-title":"Neurological manifestations of IgG4-related disease","volume":"19","author":"Baptista","year":"2017","journal-title":"Curr Treat Options Neurol"},{"key":"10.25259\/SNI_149_2022\/ref-2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1971400918806323","article-title":"IgG4-related intracranial disease","volume":"32","author":"Goulam-Houssein","year":"2019","journal-title":"Neuroradiol J"},{"key":"10.25259\/SNI_149_2022\/ref-3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"10.25259\/SNI_149_2022\/ref-4","first-page":"19","article-title":"Diagnosis and treatment of IgG4-related disease","volume":"401","author":"Kamisawa","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.25259\/SNI_149_2022\/ref-5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2169\/naika.99.97","article-title":"Autoimmune pancreatitis 5 Extra-pancreatic lesions and IgG4-related sclerotic diseases","volume":"99","author":"Kamisawa","year":"2010","journal-title":"Nihon Naika Gakkai Zasshi J Jpn Soc Intern Med"},{"key":"10.25259\/SNI_149_2022\/ref-6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00234-012-1012-1","article-title":"Radiological features of IgG4-related disease in the head, neck, and brain","volume":"54","author":"Katsura","year":"2012","journal-title":"Neuroradiology"},{"key":"10.25259\/SNI_149_2022\/ref-7","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.25259\/SNI_149_2022\/ref-8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2482-13-37","article-title":"IgG4-related intracranial hypertrophic pachymeningitis with skull hyperostosis: A case report","volume":"13","author":"Lin","year":"2013","journal-title":"BMC Surg"},{"key":"10.25259\/SNI_149_2022\/ref-9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00401-010-0746-2","article-title":"IgG4-related meningeal disease: Clinico-pathological features and proposal for diagnostic criteria","volume":"120","author":"Lindstrom","year":"2010","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.25259\/SNI_149_2022\/ref-10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jamaneurol.2014.243","article-title":"IgG4-related hypertrophic pachymeningitis: Clinical features, diagnostic criteria, and treatment","volume":"71","author":"Lu","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.25259\/SNI_149_2022\/ref-11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3960\/jslrt.54.95","article-title":"IgG4-related disease: Diagnostic methods and therapeutic strategies in Japan","volume":"54","author":"Masaki","year":"2014","journal-title":"J Clin Exp Hematop"},{"key":"10.25259\/SNI_149_2022\/ref-12","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00381-019-04187-z","article-title":"Large dural-based mass with bony hyperostosis in a 16-year-old male: IgG4-related disease mimicking lymphoplasmacyte-rich meningioma","volume":"35","author":"Nambirajan","year":"2019","journal-title":"Childs Nerv Syst"},{"key":"10.25259\/SNI_149_2022\/ref-13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00393-016-0142-y","article-title":"Treatment of IgG4-related disease : Current and future approaches","volume":"75","author":"Perugino","year":"2016","journal-title":"Z Rheumatol"},{"key":"10.25259\/SNI_149_2022\/ref-14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/practneurol-2015-001315","article-title":"Intracranial spread of IgG4-related disease via skull base foramina","volume":"16","author":"Rice","year":"2016","journal-title":"Pract Neurol"},{"key":"10.25259\/SNI_149_2022\/ref-15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.wneu.2018.06.174","article-title":"Clivus inflammatory pseudotumor associated with immunoglobulin G4-related disease","volume":"118","author":"Tang","year":"2018","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_149_2022\/ref-16","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3174\/ajnr.A3147","article-title":"MR imaging of IgG4-related disease in the head and neck and brain","volume":"33","author":"Toyoda","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.25259\/SNI_149_2022\/ref-17","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1148\/rg.315105735","article-title":"IgG4-related sclerosing disease: Autoimmune pancreatitis and extrapancreatic manifestations","volume":"31","author":"Vlachou","year":"2011","journal-title":"Radiographics"},{"key":"10.25259\/SNI_149_2022\/ref-18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","article-title":"IgG4-related disease and hypertrophic pachymeningitis","volume":"92","author":"Wallace","year":"2013","journal-title":"Medicine (Baltimore)"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/immunoglobulin-g4-related-disease-presenting-as-an-intracranial-mass-extended-from-the-infratemporal-fossa\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/immunoglobulin-g4-related-disease-presenting-as-an-intracranial-mass-extended-from-the-infratemporal-fossa\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T11:36:17Z","timestamp":1653651377000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/immunoglobulin-g4-related-disease-presenting-as-an-intracranial-mass-extended-from-the-infratemporal-fossa\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":18,"alternative-id":["10.25259\/SNI_149_2022"],"URL":"https:\/\/doi.org\/10.25259\/sni_149_2022","relation":{},"ISSN":["2152-7806"],"issn-type":[{"value":"2152-7806","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"article-number":"224"}}